Project Details
Description
Project Narrative
B cell lymphomas arise upon acquisition of mutations in genes with critical functions during normal B cell
development. This research proposal aims at elucidating how mutations targeting FOXO1, a factor with
essential roles in the control of germinal center B cell differentiation, contribute to the pathogenesis of some
aggressive variants of germinal center-derived B cell non-Hodgkin lymphomas. The results of this study are
expected to improve our understanding of the molecular and cellular mechanisms driving the pathogenesis of
these malignancies, and point to potentially relevant therapeutic strategies.
Status | Finished |
---|---|
Effective start/end date | 5/02/18 → 31/01/23 |
Funding
- National Cancer Institute: $415,431.00
- National Cancer Institute: $346,888.00
- National Cancer Institute: $403,867.00
- National Cancer Institute: $385,431.00
- National Cancer Institute: $385,431.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.